An analysis by Medco Health Solutions found that the number of children aged 19 and younger taking specialty drugs to treat rheumatoid arthritis (RA) has soared by 133% in the past 2 years, and spending on these medications has grown by 160%. The analysis, which compared the prescription data of children aged 19 and younger over the first 6 months of 2004 with the same time period in 2002, indicated that the rate of increase of spending on RA drugs for children has exceeded that of human growth hormone therapy.
Furthermore, spending on RA specialty medications is now higher than for any other biotech category. For example, for the first time, RA drugs have surpassed multiple sclerosis drugs. RA specialty medications have also shown the greatest increase in costs, making up 44% of the drug trend for the whole specialty category in 2004.
The Oncology Care Pharmacist in Health-System Pharmacy
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.
News from the year's biggest meetings
Clinical features with downloadable PDFs